21 related articles for article (PubMed ID: 38722939)
1. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis.
Shi L; Sun L; Li Q; Liang J; Yu W; Yi X; Yang X; Li Y; Han X; Zhang Y; Xuan C; Yao Z; Shang Y
Proc Natl Acad Sci U S A; 2011 May; 108(18):7541-6. PubMed ID: 21502505
[TBL] [Abstract][Full Text] [Related]
2. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth.
Yang J; Jubb AM; Pike L; Buffa FM; Turley H; Baban D; Leek R; Gatter KC; Ragoussis J; Harris AL
Cancer Res; 2010 Aug; 70(16):6456-66. PubMed ID: 20682797
[TBL] [Abstract][Full Text] [Related]
3. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
[TBL] [Abstract][Full Text] [Related]
4. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
Kim JH; Jung DY; Kim HR; Jung MH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development.
Kawazu M; Saso K; Tong KI; McQuire T; Goto K; Son DO; Wakeham A; Miyagishi M; Mak TW; Okada H
PLoS One; 2011 Mar; 6(3):e17830. PubMed ID: 21445275
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development.
Manavathi B; Samanthapudi VS; Gajulapalli VN
Front Cell Dev Biol; 2014; 2():34. PubMed ID: 25364741
[TBL] [Abstract][Full Text] [Related]
7. Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase.
Trager MH; Sah B; Chen Z; Liu L
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33928351
[TBL] [Abstract][Full Text] [Related]
8. Correction: Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development.
Kawazu M; Saso K; Tong KI; McQuire T; Goto K; Son DO; Wakeham A; Miyagishi M; Mak TW; Okada H
PLoS One; 2024; 19(5):e0303780. PubMed ID: 38722939
[TBL] [Abstract][Full Text] [Related]
9. Impact of endocrine disruptor hexachlorobenzene on the mammary gland and breast cancer: The story thus far.
Miret NV; Pontillo CA; Zárate LV; Kleiman de Pisarev D; Cocca C; Randi AS
Environ Res; 2019 Jun; 173():330-341. PubMed ID: 30951959
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
